The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.
Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment.
Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).
Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally say experts
A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.
A genetic risk factor for multiple sclerosis may also increase the risk of developing Hodgkin lymphoma, according to the Institute of Cancer Research.
People in Scotland with a type of non-Hodgkin's lymphoma, who have relapsed, will get access to MabThera on the NHS following a decision by the Scottish Medicines...
A new study, part-funded by Cancer Research UK, has discovered that ancient DNA sequences within human cells can actually help cancer cells survive.
Researchers have identified three regions of DNA that appear to increase people's risk of developing Hodgkin's lymphoma.
Giving patients fewer doses of a type of chemotherapy increases the effectiveness of a Hodgkin's lymphoma treatment, and reduces side effects, according to German...
Some children with early-stage Hodgkin's lymphoma who respond to initial chemotherapy may not need subsequent radiotherapy, according to US research.